VolitionRx Unveils Innovative Lateral Flow Test for Nucleosome Quantification at Point-of-Care Settings VolitionRx Limited presents a significant breakthrough: a lateral flow test capable of rapid nucleosome quantification in whole blood, enhancing patient outcomes in critical care.

VolitionRx Unveils Innovative Lateral Flow Test for Nucleosome Quantification at Point-of-Care Settings #United_States #Henderson #VolitionRx #nucleosome_test #SUMMIT_program